European Research in European Research in Nanosciences and Nanotechnologies Nanosciences and Nanotechnologies and Perspectives for and Perspectives for International Co-operation International Co-operation Disclaimer: Note that this presentation is not legally binding and does not represent any commitment on behalf of the European Commission http://cordis.europa.eu/nanotechnology/ [email protected]Nicholas Deliyanakis European Commission DG Research - G4 : Nano S&T and Converging Science and Technologies
European Research in Nanosciences and Nanotechnologies and Perspectives for International Co-operation . Nicholas Deliyanakis European Commission DG Research - G4 : Nano S&T and Converging Science and Technologies. http://cordis.europa.eu/nanotechnology/ [email protected]. - PowerPoint PPT Presentation
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
European Research inEuropean Research inNanosciences and NanotechnologiesNanosciences and Nanotechnologies
and Perspectives forand Perspectives forInternational Co-operation International Co-operation
Disclaimer: Note that this presentation is not legally binding and does not represent any commitment on behalf of the European Commission
DG Research - G4 : Nano S&T and Converging Science and Technologies
NanotechnologyNanotechnology
Medicine and Health
InformationTechnology
Materials Science
Food, Water and the Environment
InstrumentsEnergy Production / Storage
GMR Hard Disk
Hydrogen Fuel Cells
Lightweight and strong
Drug delivery
Tunneling microscopy
Remediation methods
Potential• to serve society by addressing important problems• to support industrial competitiveness
More knowledge Research Infrastructures Education
Capacity of application Innovation Patents Regulation
Issues to be addressed:Funding and Policy
Reliability Metrology Standards Risk assessment
Societal acceptance Balance and perception of risks and benefits Conformity to ethical principles Expected response to society needs, to people’s expectations and concernssome issues are better
addressed at local, national,EU or global level
Nanosciences and Nanotechnologies: An Action Plan
for Europe 2005-2009http://cordis.europa.eu/nanotechnology/actionplan.htm
Actions to be implemented by Commission and Member Statesfor integrated, safe and responsible policy:
1. Research & Development2. Infrastructures3. Human Resources4. Industrial Innovation5. Integrating the Societal Dimension6. Public Health, Safety, Environmental and Consumer
Protection7. International Co-operation8. Co-ordination of activities
NMP572
IST466
other36
SME17
NEST22
Health65
Infrastructures40
Marie Curie151
Background: Nanotechnology R&D in FP6Background: Nanotechnology R&D in FP6More than 1.3 billion Euro in more than 550 projects
EC funding by FP6 programme, M€
Nanotechnology R&D in Nanotechnology R&D in the Worldthe World
2004~8 Billion $
2005~10.5 Billion $
Global figures for 2005 M$ (1€ ~ 1.25$)
5901250
1380450
1000700
10602000
1700
400
0
500
1000
1500
2000
2500
3000
3500
4000
EU US Japan others
Private
States
EC / US federal
Source: EC, Lux Research
NMP FP6 projects, e.g.NMP FP6 projects, e.g.Examples of FP6 projects
•CANAPE: Carbon Nanotubes for Applications in Electronics, Catalysis, Composites and Nano-Biology – University of Cambridge (UK)•NAIMO: Nanoscale Integrated processing of self-organizing Multifunctional Organic Materials - Université Libre de Bruxelles (BE)•NANOFUN-POLY: Nanostructured and functional polymer-based materials and nanocomposites - Consorzio Interuniversitario Scienza e Tecnologia dei Materiali (IT)•RADSAS: Rational Design and Characterisation of Supramolecular Architectures on Surfaces - Eidgenössische Materialprüfungs- und Forschungsanstalt (CH)•BIOMACH: Molecular Machines - Design and Nano-Scale Handling of Biological Antetypes and Artificial Mimics - Forschungszentrum Karlsruhe GmbH (DE)•Cornea engineering: Three-dimensional reconstruction of human corneas by tissue engineering” - Centre National de la Recherche Scientifique / Rhône Alpes (FR)•Ambio: Advanced nanostructured surfaces for the control of biofouling - University of Birmingham (UK)•ANVOC: Application of nanotechnologies for separation and recovery of volatile organic compounds from waste air streams – S&T Research Council of Turkey (TR)•NANOSAFE2: Safe production and use of nanomaterials - Commissariat à l'Energie Atomique (FR)•Nanologue: Facilitating dialogue between research, business and the civil society to improve the quality of life, create wealth and reduce impacts to society - Wuppertal Institute for Climate, Energy and the Environment (DE)
Large increase in annual budget (from ~4,500 to ~7,000M€)
Integration of International Co-operation into all four programmes
Simplification of operation
Focus on developing research that meets the needs of European industry, through the work of Technology Platforms and the new Joint Technology Initiatives
Establishment of a European Research Council, funding European research on the sole basis of excellence
Support to ICPC researchers in nanotechnology and creation of a free and open electronic archive of nanosciences and nanotechnologies scientific and technical publications
NMP-2007-1.1-4CSA
Development of methodology, collection and elaboration of scientific-technical and socio-economic data and studies on nanosciences and nanotechnologies, including risk assessment, and establishment of an observatory
NMP-2007-1.1-5CSA (ERANET)
ERANET Plus in nanosciences
Funding for Nanotechnology R&D in Funding for Nanotechnology R&D in FP7FP7• More than 50 activities in the calls opened in 2007 are directly relevant• Many more activities are indirectly relevant (e.g. in Health)• 300-400M€ estimated in 2007• Doubling of the FP6 funding expected over duration of FP7NanoscienceNanoscience
Substantial innovation in the European medical industry: development of nanotechnology-based systems for in-vivo diagnosis and therapy (in coordination with topics HEALTH-2007-2.4.1-7 and HEALTH-2007-1.2-3)
HEALTH-2007-2.4.1-7CP
Improving targeted drug delivery to cancer cells for cancer therapeutics other than gene therapy
HEALTH-2007-1.2.3Large CP
Novel targeted imaging probes for early in vivo diagnosis and/or evaluation of response to therapy
NMP-2007-2.3.-1 Large CP
Highly porous bioactive scaffolds controlling angiogenesis for tissue engineering
NMP-2007-1.2-3CSA
Analysis of the ethical, regulatory, social and economic environment of nanomedicine
ICT-2007-5.1Large CP, CSA
Personal Health Systems for Monitoring and Point-of-Care diagnostics
HEALTH-2007-1.4.4Large CP 2nd call
Development of emerging gene therapy tools and technologies for clinical application
NanomedicineNanomedicine
NB: Many more activities in the Health theme are relevant to nanomedicine,e.g. imaging, stem cells and translating research for human health
a) Optimising the use and development of the best research infrastructures existing in Europe
Co-ordinated calls dedicated to nanotechnology are envisaged
b) Pooling of resources (national, private, European) to support the emergence of new facilities required by the scientific community within the next 10-20 years-European Strategy Forum on Research Infrastructures (ESFRI): http://www.cordis.europa.eu/esfri/-Integration through Networks of Excellence
Infrastructures Infrastructures actionsactions
a) Workshop on research training in N&N, 14-15 April 2005cordis.europa.eu/nanotechnology/src/educationworkshop.htm
b) Educational programmes (Erasmus Mundus, Socrates-Erasmus)
e.g. Erasmus Mundus Masters course in N&N
c) Nanotechnology Award (ongoing discussions with Science and Society directorate)
d) Joint initiatives with Marie Curie actions in FP7 are envisaged
Human Resources Human Resources actionsactions
a) Better co-operation between industry and R&D organisations, encouragement of entrepreneurship NanoForum, a European N&N gateway
•In 500 FP5 projects (Growth Programme), an average of 0.9 patents per projects were applied for and 0.4 were granted.
•In FP6 so far (sample of 35 projects), about 3 patents per project have been (or will be) filed
• ~45% from IPs• ~55% from STREPs• Most patents in: Nanobiotechnology, esp. nanomedicine, self-assembly, nanotubes,organic electronics, sensors and instruments
ADDRESSING EXPECTATIONS ANDADDRESSING EXPECTATIONS ANDCONCERNS:CONCERNS: A real partnership between science, society and policy is a key element of governance: Open dialogue with open results.
a) Ethical reviews of projects carried out, where needed
b) European Group of Ethics is assessing Nanomedicine (opinion in autumn 2006)
c) Studies and foresight activities NanoRoadSME project www.nanoroad.net NanoRoadMap project www.nanoroadmap.it
d) Social dialogue undertaken through funded projects and events Nanologue project www.nanologue.net Nanodialogue project www.nanodialogue.org “Communicating Science, A survival kit for
Scientists”ec.europa.eu/research/science-society/
pdf/communicating-science_en.pdfe) Publicity material in many languages
a) Declaration or “code of good conduct” – dedicated international dialogue (global meetings in Alexandria (US), 2004, Tokyo, 2006, and Brussels, 2007)
b) Issues of mutual benefit - (i) a new ISO group is operational, (ii) OECD is becoming increasingly active and (iii) a co-ordinated EU/USA call for proposals in (eco)toxicology is being negotiated
c) Database of publications: Addressed in the first FP7 call for proposals
International Cooperation International Cooperation actionsactions
General principles on General principles on international co-operationinternational co-operation
The Commission seeks international debate on nanotechnology-related issues such as public health, safety, environment, consumer protection, risk assessment, metrology, norms, …;
The EU R&D programmes are open to the World; Europe even funds research teams in Third Countries;
Europe promotes the monitoring and sharing at international level of information related to the scientific, technological, economical & social development of nanotechnology;
Europe strives for an international “code of conduct” for the responsible development of nanotechnology,
and to avoid a “nano-divide”.
Main International Fora and Initiatives on Nanotechnology
ISO, IEEE, Int. Comm.Weights & Measures
standardisation, metrology
IRGC, ICONabout risksindustry-led
OECD CSTPproposed WP on nanotechnology
OECD NESTInanotechnology
indicatorsUNESCO
ethics incl. risk assessment
G8 Carnegie Group
coordinationby ICGB
OECD JM CHEMICALSWP safety nanomaterials
characterisation, metrology, toxicity, …
OECD Global Science Forum World Social Forum
Global (informal)governmental dialogue
on responsiblenanotechnology
incl. governance & societal dialogue
Observatory?
World Economic Forum
APEC, ANF, NEPADmacro-regions
INCindustry-led
Meridian Inst.,UNIDO, NEPADagainst « divide »
a) Creation of a Commission Interservice Group to monitor and oversee the implementation of the Action Plan, see cordis.europa.eu/nanotechnology/src/contacts.htm
It is important to have a regular interaction with Member States (currently: Council Research working party; a “nano” group for international cooperation; and groups for regulation)
b) Reporting: We plan to issue a report at the end of 2007 and one at the end of 2009
c) Activities to foster beneficial applications: addressed in proposals for FP7 calls for proposals